Dialysis for a patient who had congenital deficiency of alpha 2-plasmin inhibitor. 1998

M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira

UI MeSH Term Description Entries
D008297 Male Males
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D000979 alpha-2-Antiplasmin A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. alpha 2-Plasmin Inhibitor,Serpin F2,alpha(2)-Plasmin Inhibitor,alpha-2 Antiplasmin,alpha 2 Antiplasmin,alpha 2 Plasmin Inhibitor
D014148 Tranexamic Acid Antifibrinolytic hemostatic used in severe hemorrhage. AMCHA,AMCA,Amchafibrin,Anvitoff,Cyklokapron,Exacyl,KABI 2161,Spotof,Transamin,Ugurol,t-AMCHA,trans-4-(Aminomethyl)cyclohexanecarboxylic Acid

Related Publications

M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
January 1998, Ryoikibetsu shokogun shirizu,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
April 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
March 1980, Blood,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
December 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
May 1981, Thrombosis research,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
February 1979, Lancet (London, England),
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
January 1982, Haemostasis,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
May 1979, The Journal of clinical investigation,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
July 2001, British journal of haematology,
M Tatematsu, and A Higa, and H Sunagawa, and O Ikehara, and Y Shiohira
July 1990, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!